
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rhapsody Venture Partners is a venture capital firm founded in 2016 and based in Cambridge, Massachusetts. The firm focuses on supporting scientific founders in commercializing hard science innovations. Rhapsody aims to bridge the gap between laboratory research and market-ready products, addressing significant industrial challenges through investments in materials science and sustainable materials.
The firm has a team of experienced entrepreneurs and business development executives who work closely with portfolio companies to ensure market fit and accelerate growth. Rhapsody Venture Partners has a portfolio of 27 companies, showcasing its commitment to fostering innovation in various sectors. The firm actively screens around 2,000 startups annually, identifying promising opportunities in fields such as physics, chemistry, and applied sciences.
Rhapsody's notable milestones include investments in companies like Apeel Sciences, which has achieved unicorn status, and SAFI-Tech, which has been acquired. The firm emphasizes collaboration with industry strategics to enhance the commercialization process for its portfolio companies.
Rhapsody Venture Partners invests exclusively at the seed stage, with initial investments typically ranging from $500,000 to $2 million. The firm prioritizes early partnerships with industry strategics to ensure that portfolio companies achieve market fit and accelerate their time to market. Rhapsody's investment strategy encompasses sectors such as materials science, sustainable materials, agriculture, manufacturing, and electronics.
The firm screens approximately 2,000 startups each year, focusing on hard science startups that address industrial problems. Rhapsody seeks to partner with founders who demonstrate a strong scientific background and a clear vision for their technology's application in the market. The firm often leads larger syndicates in follow-on rounds, further supporting its portfolio companies as they scale.
Rhapsody Venture Partners has invested in a diverse range of companies, including:
Notable exits from Rhapsody's portfolio include the unicorn Apeel Sciences, which focuses on food preservation, and SAFI-Tech, which has been acquired. These successes highlight Rhapsody's effective investment strategy in hard science startups.
Startups interested in pitching to Rhapsody Venture Partners should submit their proposals through the firm's website at rhapsodyvp.com. The pitch deck should include a detailed overview of the technology, market analysis, and the founding team's background. Rhapsody prefers to receive warm introductions but is open to direct submissions as well.
Founders can expect a response within a few weeks, depending on the volume of submissions. It is advisable to clearly outline the startup's unique value proposition and any traction achieved to date.
As of October 2025, Rhapsody Venture Partners has made two new investments in the last 12 months, maintaining an active presence in the venture capital ecosystem. The firm continues to focus on seed-stage investments in hard science startups, reinforcing its commitment to supporting scientific founders.
Recent portfolio highlights include the continued growth of companies like Chinova and NODAR, both of which are innovating in their respective fields. Rhapsody's emphasis on partnerships with industry strategics remains a key aspect of its investment strategy, ensuring that portfolio companies are well-positioned for market success.
What are Rhapsody Venture Partners' investment criteria?
Rhapsody Venture Partners invests exclusively in hard science startups that address significant industrial problems. They focus on seed-stage investments, typically ranging from $500,000 to $2 million.
How can startups apply or pitch to Rhapsody?
Startups can pitch to Rhapsody Venture Partners through their website at rhapsodyvp.com. They encourage founders to provide a clear overview of their technology and its market application.
What makes Rhapsody different from other venture capital firms?
Rhapsody emphasizes deep partnerships with industry strategics and a hands-on approach, embedding within portfolio companies to ensure market fit and accelerate commercialization.
What is Rhapsody's geographic focus?
Rhapsody Venture Partners primarily invests in startups based in the United States, focusing on hard science innovations.
What is Rhapsody's post-investment involvement like?
The firm actively engages with portfolio companies, providing operational support and facilitating connections with industry partners to enhance growth and market readiness.
What is the typical check size for Rhapsody's investments?
Rhapsody typically invests between $500,000 and $2 million in seed-stage rounds, often leading larger syndicates in follow-on funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.